Question? Call us
212-363-7500Expired
Lead Plaintiff Deadline
Aug 5, 2019
Choose your preferred way to stay informed of new case launches and settlement deadlines
(i) Heron had failed to include adequate Chemistry, Manufacturing, and Controls (“CMC”) and non-clinical information in its NDA for HTX-011; (ii) the foregoing increased the likelihood that the FDA would not approve Heron’s NDA for HTX-011; and (iii) as a result, Heron’s public statements were materially false and misleading at all relevant times.
In order to be eligible to join the HRTX class action lawsuit, you must have incurred a loss on shares of purchased during the class period listed above.
If you suffered a loss in during the relevant time frame or pursuant to the relevant offering(s), you have until August 5, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP